Document:

Exhibit 10.58

 

APPROVED BY STOCKHOLDERS

ON MAY 17, 2000

 

INAMED CORPORATION

1999 STOCK OPTION PLAN

 

1. 
Purpose.  The purpose
of the Plan is to provide additional incentive to those officers, key
employees, non-employee directors and consultants of the Company and its
Subsidiaries whose substantial contributions are essential to the continued
growth and success of the Company’s business in order to strengthen their
commitment to the Company and its Subsidiaries, to motivate such officers and
employees to faithfully and diligently perform their assigned responsibilities
and to attract and retain competent and dedicated individuals whose efforts
will result in the long-term growth and profitability of the Company. To
accomplish such purposes, the Plan provides that the Company may grant
Nonqualified Stock Options. The Plan is intended, to the extent applicable, to
satisfy the requirements of Section 162(m) of the Code and shall be
interpreted in a manner consistent with the requirements thereof.

 

2. 
Definitions.  For
purposes of the Plan:

 

(a)               “Affiliates” shall have the meaning set
forth in Rule 12b-2 under the Exchange Act.

 

(b)              “Agreement” shall mean the written
agreement evidencing the grant of an Option, and setting forth the terms and
conditions thereof. Each Agreement shall be approved by the Board or the
Committee.

 

(c)               “Associates” shall have the meaning set
forth in Rule 12b-2 under the Exchange Act.

 

(d)              “Beneficial Owner” shall have the meaning
set forth in Rule 13d-3 under the Exchange Act.

 

(e)               “Board” shall mean the Board of
Directors of the Company.

 

(f)                 “Change in Capitalization” shall mean
any increase, reduction, or change or exchange of Shares for a different number
or kind of shares or other securities of the Company by reason of a reclassification,
recapitalization, merger, consolidation, reorganization, issuance of warrants
or rights, stock dividend, stock split or reverse stock split, combination or
exchange of shares, repurchase of shares, change in corporate structure or
otherwise.

 

(g)              “Change of Control” of the Company shall
be deemed to occur on the first to occur of the following: (i) any Person
(other than the Company, any trustee or other fiduciary holding securities
under an employee benefit plan of the Company, or any corporation owned,
directly or indirectly, by the stockholders of the Company in substantially the
same proportions as their ownership of stock of the Company)), is or becomes
the Beneficial Owner, directly or indirectly, of securities of the Company
representing 20% or more (or, in the case of Appaloosa Management, L.P. and its
Affiliates and Associates, 36% or more) of the combined voting power of the
Company’s then outstanding securities; (ii) during any period of two
consecutive years (not including any period prior to the adoption of the Plan),
individuals who at the beginning of such period constitute the Board, and any
new director (other than a director designated by a person who has entered into
an agreement with the Company to effect a transaction described in clause (i),
(iii) or (iv) of this definition) whose election by the Board or
nomination for election by the Company’s stockholders was approved by a vote of
at least two-thirds ( 2¤3) of
the directors then still in office who either were directors at the beginning
of the period or whose election or nomination for election was previously so
approved, cease for any reason to constitute at least a majority thereof;
(iii) the stockholders of the Company approve a merger or consolidation of
the Company with any other corporation, other than (a) a merger or
consolidation which would result in the voting securities of the Company
outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the

 

 

surviving entity) more than 50% of the combined voting power of the
voting securities of the Company or such surviving entity outstanding
immediately after such merger or consolidation, or (b) a merger or
consolidation effected to implement a recapitalization of the Company (or
similar transaction) in which no Person acquires more than 20% of the combined
voting power of the Company’s then outstanding securities; or (iv) the
stockholders of the Company approve a plan of complete liquidation of the
Company or an agreement for the sale or disposition by the Company of all or
substantially all of the Company’s assets.

 

(h)              “Code” shall mean the Internal Revenue
Code of 1986, as amended.

 

(i)                  “Committee” shall mean a committee
appointed by the Board to administer the Plan and to perform the functions set
forth herein. The composition of the Committee shall at all times consist
solely of persons who are (i) “Nonemployee Directors” as defined in
Rule 16b-3 issued under the Exchange Act, and (ii) “outside directors”
as defined in Section 162(m) of the Code.

 

(j)                  “Company” shall mean Inamed
Corporation, a Delaware corporation.

 

(k)               “Eligible Employee” shall mean any
officer or other key employee of the Company or a Subsidiary designated by the
Board or Committee as eligible to receive Options subject to the conditions set
forth herein.

 

(l)                  “Exchange Act” shall mean the
Securities Exchange Act of 1934, as amended.

 

(m)            “Fair Market Value” shall mean the fair
market value of the Shares as determined by the Committee in its sole
discretion; provided, however, that (A) if the Shares are
admitted to trading on a national securities exchange, Fair Market Value on any
date shall be the last sale price reported for the Shares on such exchange on
such date or on the last date preceding such date on which a sale was reported,
(B) if the Shares are admitted to quotation on the NASDAQ stock market (“NASDAQ”)
or other comparable quotation system and have been designated as a National
Market System (“NMS”) security, Fair Market Value on any date shall be the last
sale price reported for the Shares on such system on such date or on the last
day preceding such date on which a sale was reported, or (C) if the Shares
are admitted to quotation on NASDAQ and have not been designated a NMS
security, Fair Market Value on any date shall be the average of the highest bid
and lowest asked prices of the Shares on such system on such date.

 

(n)              “Incentive Stock Option” shall mean an “Incentive
Stock Option” within the meaning of Section 422 of the Code.

 

(o)              “Nonqualified Stock Option” shall mean an
option that is not an Incentive Stock Option.

 

(p)              “Option” shall mean a Nonqualified Stock
Option.

 

(q)              “Optionee” shall mean an Eligible
Employee, nonemployee director or consultant of the Company or a Subsidiary who
has been granted an Option under the Plan.

 

(r)                 “Person” shall have the meaning given
in Section 3(a)(9) of the Exchange Act, as modified and used in Sections
13(d) and 14(d) thereof.

 

(s)               “Plan” shall mean the Inamed Corporation
1999 Stock Option Plan, as amended from time to time.

 

(t)                 “Shares” shall mean shares of the
common stock, $.01 par value, of the Company (including any new, additional or
different stock or securities resulting from a Change in Capitalization).

 

(u)              “Subsidiary” shall mean any corporation
in an unbroken chain of corporations, beginning with the Company, if each of
the corporations other than the last corporation in the unbroken

 

2

 

chain owns stock possessing 50% or more of the total combined voting
power of all classes of stock in one of the other corporations in such chain.

 

3. 
Administration.

 

(a)               The Plan shall be administered by the
Committee, which shall hold meetings at such times as may be necessary for the
proper administration of the Plan. The Committee shall keep minutes of its
meetings. A majority of the Committee shall constitute a quorum and a majority
of a quorum may authorize any action. Any decision reduced to writing and
signed by a majority of the members of the Committee shall be fully effective
as if it had been made at a meeting duly held. No member of the Committee shall
be personally liable for any action, determination or interpretation made in
good faith with respect to the Plan and all members of the Committee shall be
fully indemnified by the Company with respect to any such action, determination
or interpretation. The Company shall pay all expenses incurred in the
administration of the Plan.

 

(b)              Subject to the express terms and
conditions set forth herein, the Committee shall have the power from time to
time:

 

(i)                    to determine
those Eligible Employees, nonemployee directors and consultants to whom Options
shall be granted under the Plan and the number of Options, to be granted to
each Eligible Employee, nonemployee directors or consultants and to prescribe
the terms and conditions (which need not be identical) of each Option,
including the purchase price per Share of each Option;

 

(ii)                 to construe and
interpret the Plan and the Options granted hereunder and to establish, amend
and revoke rules and regulations for the administration of the Plan, including,
but not limited to, correcting any defect or supplying any omission, or
reconciling any inconsistency in the Plan or in any Agreement, in the manner
and to the extent it shall deem necessary or advisable to make the Plan fully
effective, and all decisions and determinations by the Committee in the
exercise of this power shall be final and binding upon the Company or a
Subsidiary, and the Optionees, as the case may be;

 

(iii)              generally, to
exercise such powers and to perform such acts as are deemed necessary or
advisable to promote the best interests of the Company with respect to the
Plan.

 

4. 
Shares Subject to Plan; Limitation on Grants.

 

(a)               The maximum number of Shares that may be
issued pursuant to Options shall be 900,000 Shares (or the number and kind of
shares of stock or other securities that are substituted for those Shares or to
which those Shares are adjusted upon a Change in Capitalization), and the
Company shall reserve for the purposes of the Plan, out of its authorized but
unissued Shares or out of Shares held in the Company’s treasury, or partly out
of each, such number of Shares.

 

(b)              Whenever any outstanding Option or
portion thereof expires, is cancelled or is otherwise terminated (other than by
exercise of an Option), the Shares allocable to the unexercised portion of such
Option may again be the subject of grants of Options hereunder.

 

(c)               The aggregate number of Shares with
respect to which an Option or Options may be granted to any individual Optionee
during any fiscal year shall not exceed 300,000.

 

5. 
Eligibility.  Subject to the provisions of the
Plan, the Committee shall have full and final authority to select those
Eligible Employees, nonemployee directors and consultants who will receive
Options hereunder.

 

3

 

6. 
Options.  The Committee
may grant Options in accordance with the Plan, the terms and conditions of
which shall be set forth in an Agreement. Each Option and Agreement shall be
subject to the following conditions:

 

(a)  Purchase Price.  The purchase price or the manner in which the
purchase price is to be determined for Shares under each Option shall be set
forth in the Agreement; provided,
however, that the Board may, in
its sole discretion, at any time prior to the expiration of an Option, provide
that the purchase price per Share of an Option may be lowered if the Board
determines that such an adjustment is necessary to preserve the incentive
purpose of such Option.

 

(b)  Duration.  Options
granted hereunder shall be for such term as the Committee shall determine,
provided that no Option shall be exercisable after the expiration of ten
(10) years from the date it is granted. The Committee may, subsequent to
the granting of any Option, extend the term thereof but in no event shall the
term as so extended exceed the maximum term provided for in the preceding
sentence.

 

(c)  Nontransferability. 
Unless otherwise set forth in the Agreement, no Option granted hereunder
shall be transferable by an Optionee otherwise than by will or the laws of
descent and distribution, and an Option may be exercised during the lifetime of
such Optionee only by the Optionee or such Optionee’s guardian or legal
representative. The terms of such Option shall be binding upon the
beneficiaries, executors, administrators, heirs and successors of the Optionee.

 

(d)  Vesting.  Each Option
shall become exercisable as determined by the Board or Committee as set forth
in the Agreement.

 

(e)  Termination of Employment or Service.  Unless otherwise set forth in the Agreement,
any outstanding Options held by an Optionee on the date that an Optionee ceases
to be employed by the Company or any Subsidiary (or ceases to serve as a
nonemployee director of, or a consultant to the Company or any Subsidiary)
shall terminate as of such date. Notwithstanding the foregoing, the Committee
may provide, either at the time an Option is granted or thereafter, that the
Option may be exercised beyond such date, but in no event beyond the term of
the Option. Without limiting the generality of the foregoing, unless determined
otherwise by the Committee and reflected in the applicable Agreement, service
by an Optionee as a consultant to the Company which commences immediately upon
the termination of such Optionee’s employment by the Company (or, if
applicable, termination of such Optionee’s service as a nonemployee director)
shall be treated as continuous service by such Optionee with the Company for
purposes of this Plan, and Options held by such Optionee shall remain
outstanding during such service as a consultant, subject to the terms of the
Agreement and the Plan.

 

(f)  Method of Exercise.  The exercise of an Option shall be made only
by a written notice delivered to the Secretary of the Company at the Company’s
principal executive office, specifying the number of Shares to be purchased and
accompanied by payment therefor and otherwise in accordance with the Agreement
pursuant to which the Option was granted. The purchase price for any Shares
purchased pursuant to the exercise of an Option shall be paid in full upon such
exercise either (i) in cash, by certified check or by cashier’s check or
(ii) through the delivery of Shares owned by the Optionee for at least six
months prior to the date of exercise having a Fair Market Value equal to the
Option purchase price. If requested by the Committee, the Optionee shall
deliver the Agreement evidencing the Option to the Secretary of the Company who
shall endorse thereon a notation of such exercise and return such Agreement to
the Optionee. Not less than 50 Shares may be purchased at any time upon the
exercise of an Option unless the number of Shares so purchased constitutes the
total number of Shares then purchasable under the Option.

 

(i)  Rights of Optionees. 
No Optionee shall be deemed for any purpose to be the owner of any
Shares subject to any Option unless and until (i) the Option shall have
been exercised

 

4

 

pursuant to the terms thereof, (ii) the Company shall have issued
and delivered the Shares to the Optionee, and (iii) the Optionee’s name
shall have been entered as a stockholder of record on the books of the Company.
Thereupon, the Optionee shall have full voting, dividend and other ownership
rights with respect to such Shares.

 

7. 
Adjustment Upon Changes in Capitalization.

 

(a)               In the event of a Change in
Capitalization, the Committee shall conclusively determine the appropriate
adjustments, if any, to the maximum number and class of shares of stock with
respect to which Options may be granted under the Plan, the number and class of
shares of stock as to which Options have been granted under the Plan, and the purchase
price therefor, if applicable.

 

(b)              In the event the outstanding Shares shall
be changed into or exchanged for any other class or series of capital stock or
cash, securities or other property pursuant to a recapitalization,
reclassification, merger, consolidation, combination or similar transaction,
then each Option shall thereafter become exercisable for the number and/or kind
of capital stock, and/or the amount of cash, securities or other property so
distributed, into which the Shares subject to the Option would have been
changed or exchanged had the Option been exercised in full prior to such
transaction, provided that, if the kind or amount of capital stock or cash,
securities or other property received in such transaction is not the same for each
outstanding Share, then the kind or amount of capital stock or cash, securities
or other property for which the Option shall thereafter become exercisable
shall be the kind and amount so receivable per Share by a plurality of the
Shares, and provided further that, if necessary, the provisions of the Option
shall be appropriately adjusted so as to be applicable, as nearly as may
reasonably be, to any shares of capital stock, cash, securities or other
property thereafter issuable or deliverable upon exercise of the Option.

 

8. 
Termination and Amendment of the Plan.  The Plan shall terminate on the day preceding
the tenth anniversary of its effective date, except with respect to Options
outstanding on such date, and no Options may be granted thereafter, but
then-outstanding Options shall be unaffected. The Board may sooner terminate or
amend the Plan at any time, and from time to time; provided, however, that,
except as provided in Section 7 hereof, no amendment shall be effective
unless approved by the stockholders of the Company if and to the extent that
the Board determines such approval is appropriate for purposes of satisfying
Section 162(m) of the Code or any other law, regulation or stock exchange
rule. Except as provided in Section 7 hereof, rights and obligations under
any Option granted before any amendment of the Plan shall not be adversely
altered or impaired by such amendment, except with the consent of the Optionee.

 

9. 
Nonexclusivity of the Plan. 
The adoption of the Plan by the Board shall not be construed as
amending, modifying or rescinding any previously approved incentive arrangement
or as creating any limitations on the power of the Board to adopt such other
incentive arrangements as it may deem desirable, including, without limitation,
the granting of stock options otherwise than under the Plan, and such
arrangements may be either applicable generally or only in specific cases.

 

10. 
Limitation of Liability. 
As illustrative of the limitations of liability of the Company, but not
intended to be exhaustive thereof, nothing in the Plan shall be construed to:

 

(a)               give any person any right to be granted
an Option other than at the sole discretion of the Board or the Committee;

 

(b)              give any person any rights whatsoever
with respect to Shares except as specifically provided in the Plan;

 

(c)               limit in any way the right of the
Company or its Subsidiaries to terminate the employment of any person at any
time; or

 

5

 

(d)              be evidence of any agreement or
understanding, expressed or implied, that the Company or its Subsidiaries will
employ any person in any particular position, at any particular rate of
compensation or for any particular period of time.

 

11. 
Regulations and Other Approvals; Governing Law.

 

(a)               The Plan and the rights of all persons
claiming hereunder shall be construed and determined in accordance with the
laws of the State of Delaware without giving effect to the choice of law
principles thereof.

 

(b)              The obligation of the Company to sell or
deliver Shares with respect to Options granted under the Plan shall be subject
to all applicable laws, rules and regulations, including all applicable federal
and state securities laws, and the obtaining of all such approvals by
governmental agencies as may be deemed necessary or appropriate by the
Committee.

 

(c)               Except as otherwise provided in
Section 8, the Board may make such changes as may be necessary or
appropriate to comply with the rules and regulations of any government
authority.

 

(d)              Each Option is subject to the requirement
that, if at any time the Committee determines, in its absolute discretion, that
the listing, registration or qualification of Shares issuable pursuant to the
Plan is required by any securities exchange or under any state or federal law,
or the consent or approval of any governmental regulatory body is necessary or
desirable as a condition of, or in connection with, the grant of an Option, or
the issuance of Shares, no Options, shall be granted or payment made or Shares
issued, in whole or in part, unless listing, registration, qualification,
consent or approval has been effected or obtained free of any conditions as
acceptable to the Committee.

 

12. 
Multiple Agreements. 
The terms of each Option may differ from other Options granted under the
Plan at the same time, or at any other time. The Committee may also grant more
than one Option, to a given Optionee during the term of the Plan, either in
addition to, or in substitution for, one or more Options previously granted to
that Optionee. The grant of multiple Options may be evidenced by a single
Agreement or multiple Agreements, as determined by the Committee.

 

13. 
Withholding of Taxes. 
Whenever Shares are to be delivered pursuant to an Option, the Company
shall have the right to require the Optionee to remit to the Company in cash an
amount equal to the amount of any federal, state and local tax required to be
withheld. With the approval of the Committee, an Optionee may satisfy the
foregoing requirement by electing to have the Company withhold from delivery
Shares having a value equal to the amount of tax to required to be withheld.
Such Shares shall be valued at their Fair Market Value on the date of which the
amount of tax required to be withheld is determined (the “Tax Date”).
Fractional share amounts shall be settled in cash. Such a withholding election
may be made with respect to all or any portion of the shares to be delivered
pursuant to an Option.

 

14. 
Notification of Election Under Section 83(b) of the Code.  If any Optionee shall, in connection with the
acquisition of Shares under the Plan, make the election permitted under
Section 83(b) of the Code, such Optionee shall notify the Company of such
election within 10 days of filing notice of the election with the Internal
Revenue Service.

 

15. 
No Fractional Shares. 
No fractional Shares shall be issued or delivered pursuant to the Plan.
The Board shall determine whether cash, other Options, or other property shall
be issued or paid in lieu of such fractional shares or whether such fractional
shares or any rights thereto shall be forfeited or otherwise eliminated.

 

16. 
Beneficiary.  An
Optionee may file with the Committee a written designation of a beneficiary on
such form as may be prescribed by the Committee and may, from time to time,
amend or revoke such designation. If no designated beneficiary survives the
Optionee, the executor or administrator of the Optionee’s estate shall be
deemed to be the Optionee’s beneficiary.

 

17. 
Effective Date.  The
effective date of the Plan is September 12, 1999 (the date on which the
Board adopted the Plan), subject to the approval of the Company’s shareholders,
which occurred on May 17, 2000.

 

6Exhibit 10.24

Cypress Bioscience

2005 Bonus Plan

On February 8, 2005, the Compensation Committee
of the Board of Directors of the Company adopted a Bonus Plan for the officers
of the Company. The Bonus Plan was adopted to provide an outcome-based annual
cash incentive to the officers of the Company. Pursuant to the Bonus Plan, the
officers of the Company are eligible to receive cash bonuses up to between 25%
to 66 2/3% of base salary, depending on the applicable participant’s position
at the Company, for the year ended December 31, 2004 and the year ending December 31,
2005. The bonuses are contingent upon the Company’s achievement of certain
corporate goals related to clinical development of the Company’s current
product, milnacipran, new product opportunities and an increase in stockholder
value. The Compensation Committee established these corporate goals and the
timelines for their achievement at the February 8th meeting. Individual
awards will be pro rated for a partial year of service. Awards based on the
applicable participants’ base salaries for the year ended December 31,
2004, if any, will be paid upon achievement of the corporate goals established
by the Compensation Committee. Awards, if any, based on the applicable
participants’ base salaries for the year ending December 31, 2005 will be
paid upon the earlier of (1) achievement of all the corporate goals
established by the Compensation Committee or (2) January 31, 2006
with respect to the corporate goals established by the Compensation Committee
and achieved by that date. These awards are only payable if the participant
continues to be employed on the date of payment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}]]